Close
Solutions
Online Inquiry
Global Services

CellRapeutics™ Phagocytosis Assay

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Based on the outstanding expertise and rich experience, Creative Biolabs has specially developed a systematic approach of phagocytosis assays. Our phagocytosis assay services are designed to help you analyze the function of specialized immune cells known as macrophages, or evaluate the effect of antibodies and vaccine, or screening TLR ligands, phagocytosis activators and inhibitors.

Introduction of Phagocytosis

Phagocytosis is an important physiological activity of specialized immune cells, often a phagocyte. The phagocytic cells of the immune system include macrophages, neutrophils, and dendritic cells. All the three types of cells have phagocytic functions. The phagocytosis is the first and immediate line of defense against foreign pathogens. Additionally, some phagocytes, including macrophages, also participate in specific immunity, playing a role in the early and advanced stage of it.

The macrophages can recognize and engulf either pathogeny or antigen-antibody complex. In our bodies, the phagocytosis can be activated by attachment to pathogen-associated molecular patterns, which leads to NF-κB activation. Activated phagocytes will then ingeste foreign particles, bacteria, and dead or dying cells by engulfing them to form an internal compartment known as a phagosome. In an organism's immune system, phagocytosis is a principal mechanism used to eliminate pathogens and clear cell debris. In other words, it is crucial in fighting infections, as well as in maintaining healthy tissues.

This computer artwork depicts phagocytosis as a macrophage white blood cell engulfs bacteria (orange).

Fig.1 This computer artwork depicts phagocytosis as a macrophage white blood cell engulfs bacteria (orange).

Phagocytosis Assays

There are many types of phagocytosis assays. By quantifying the engulfment of one of these substrates by macrophages or other phagocytes, we can get the phagocytic efficiency, and then evaluate the effect of antibodies, vaccine, ligands, and so on. In general, the phagocytosis assay can be divided into two categories, in vivo and in vitro. Both of them are always based on fluorescence. In vivo assay has advantages to be more useful and credible, while in vitro phagocytosis assay could give insights during an early stage in a very short timeline. There are many methods to carry out in vitro phagocytosis assays, including flow assay based on flow cytometry and classical phagocytosis assay. They differ in assay components and readout system. In terms of the evaluation of vaccine effectiveness, the flow assay might be more suitable for the evaluation of conjugate vaccine efficacy than for the evaluation of the conventional vaccine. The preference for either flow or killing assay will depend on which criteria are most important in a particular situation.

Creative Biolabs has the capability to enable you to free up your time for core work and project. Our service can be designed to meet your special needs if you have any requirements. If you are interested in our service, please feel free to contact us and our team will get back to you as soon as possible.

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.